SK Biopharmaceuticals IPO Book-Building Results & Ramifications
Yes, it is a new record. The competition rate is 836 to 1, which is the highest among the ₩500bil+ IPOs in Korea. The previous record-holder was...
376 Views
Trading Strategy for SK Biopharm Post IPO Pricing
SK Biopharm announced its stellar IPO book building results today. The IPO price has been confirmed at 49,000 won, which is at the high end of the...
379 Views
Aproele IPO Valuation Analysis
To value Aproele, we used an 18.2x P/E multiple based on our 2021 net profit estimate of 8.9 billion won. The valuation multiple of 18.2x was...
306 Views
SK Biopharmaceuticals Valuation Issues
One of the most debated issues during the book-building for SK Biopharm must be valuation.The bankers took an incredibly simple approach here. They...
331 Views
SK Holdings: Time to Take Profits
Given the tremendous recent outperformance of SK Holdings, we believe this is a good time to take some profits on this stock. SK Holdings (034730...
328 Views